MedTrace Logo

Role of Indomethacin in Difficult Embryo Transfer.

NCT02642601 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-12-30

No results posted yet for this study

Summary

the aim of the study is to assess the role of indomethacin in cases of difficult embryo transfer in intracytoplasmic sperm injection cycles.

Conditions

  • Difficult Embryo Transfer

Interventions

DRUG

Indomethacin(KAHIRA PHARMA&CHEM,IND,CO.CAIRO-EGYPT)

one dose of indomethacin 100 mg rectal suppository 1- 2 hours before embryo transfer

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mona M Shaban, MD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02642601 on ClinicalTrials.gov